ECONOMIC EVALUATION OF INTERFERON (a)over-capETA-1A VERSUS INTERFERON (a)over-capETA-1B IN THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) IN IRAN
dc.contributor.author | Golestani, M | |
dc.contributor.author | Rasekh, H | |
dc.contributor.author | Imani, A | |
dc.date.accessioned | 2018-08-26T08:04:20Z | |
dc.date.available | 2018-08-26T08:04:20Z | |
dc.date.issued | 2012 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/49538 | |
dc.language.iso | English | |
dc.relation.ispartof | VALUE IN HEALTH | |
dc.title | ECONOMIC EVALUATION OF INTERFERON (a)over-capETA-1A VERSUS INTERFERON (a)over-capETA-1B IN THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) IN IRAN | |
dc.type | Meeting Abstract | |
dc.citation.volume | 15 | |
dc.citation.issue | 7 | |
dc.citation.spage | A676 | |
dc.citation.epage | A676 | |
dc.citation.index | Web of science | |
dc.identifier.DOI | https://doi.org/10.1016/j.jval.2012.08.436 |